These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 12196101)
1. Effect of multiple phosphorylation events on the transcription factors FKHR, FKHRL1 and AFX. Woods YL; Rena G Biochem Soc Trans; 2002 Aug; 30(4):391-7. PubMed ID: 12196101 [TBL] [Abstract][Full Text] [Related]
2. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. Rena G; Prescott AR; Guo S; Cohen P; Unterman TG Biochem J; 2001 Mar; 354(Pt 3):605-12. PubMed ID: 11237865 [TBL] [Abstract][Full Text] [Related]
3. Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins. Richards JS; Sharma SC; Falender AE; Lo YH Mol Endocrinol; 2002 Mar; 16(3):580-99. PubMed ID: 11875118 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. Rena G; Guo S; Cichy SC; Unterman TG; Cohen P J Biol Chem; 1999 Jun; 274(24):17179-83. PubMed ID: 10358075 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. Guo S; Rena G; Cichy S; He X; Cohen P; Unterman T J Biol Chem; 1999 Jun; 274(24):17184-92. PubMed ID: 10358076 [TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways. Cahill CM; Tzivion G; Nasrin N; Ogg S; Dore J; Ruvkun G; Alexander-Bridges M J Biol Chem; 2001 Apr; 276(16):13402-10. PubMed ID: 11124266 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells. Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146 [TBL] [Abstract][Full Text] [Related]
9. Follicle-stimulating hormone promotes nuclear exclusion of the forkhead transcription factor FoxO1a via phosphatidylinositol 3-kinase in porcine granulosa cells. Cunningham MA; Zhu Q; Unterman TG; Hammond JM Endocrinology; 2003 Dec; 144(12):5585-94. PubMed ID: 12960025 [TBL] [Abstract][Full Text] [Related]
10. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Woods YL; Rena G; Morrice N; Barthel A; Becker W; Guo S; Unterman TG; Cohen P Biochem J; 2001 May; 355(Pt 3):597-607. PubMed ID: 11311120 [TBL] [Abstract][Full Text] [Related]
11. Insulin inhibits the activation of transcription by a C-terminal fragment of the forkhead transcription factor FKHR. A mechanism for insulin inhibition of insulin-like growth factor-binding protein-1 transcription. Tomizawa M; Kumar A; Perrot V; Nakae J; Accili D; Rechler MM J Biol Chem; 2000 Mar; 275(10):7289-95. PubMed ID: 10702299 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin. Arimoto-Ishida E; Ohmichi M; Mabuchi S; Takahashi T; Ohshima C; Hayakawa J; Kimura A; Takahashi K; Nishio Y; Sakata M; Kurachi H; Tasaka K; Murata Y Endocrinology; 2004 Apr; 145(4):2014-22. PubMed ID: 14701673 [TBL] [Abstract][Full Text] [Related]
14. In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. Collins BJ; Deak M; Arthur JS; Armit LJ; Alessi DR EMBO J; 2003 Aug; 22(16):4202-11. PubMed ID: 12912918 [TBL] [Abstract][Full Text] [Related]
15. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Daitoku H; Yamagata K; Matsuzaki H; Hatta M; Fukamizu A Diabetes; 2003 Mar; 52(3):642-9. PubMed ID: 12606503 [TBL] [Abstract][Full Text] [Related]
16. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Birkenkamp KU; Coffer PJ Biochem Soc Trans; 2003 Feb; 31(Pt 1):292-7. PubMed ID: 12546704 [TBL] [Abstract][Full Text] [Related]
17. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. Dijkers PF; Birkenkamp KU; Lam EW; Thomas NS; Lammers JW; Koenderman L; Coffer PJ J Cell Biol; 2002 Feb; 156(3):531-42. PubMed ID: 11815629 [TBL] [Abstract][Full Text] [Related]
18. Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1. Andreucci M; Michael A; Kramers C; Park KM; Chen A; Matthaeus T; Alessandrini A; Haq S; Force T; Bonventre JV Kidney Int; 2003 Oct; 64(4):1189-98. PubMed ID: 12969136 [TBL] [Abstract][Full Text] [Related]
19. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Takaishi H; Konishi H; Matsuzaki H; Ono Y; Shirai Y; Saito N; Kitamura T; Ogawa W; Kasuga M; Kikkawa U; Nishizuka Y Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11836-41. PubMed ID: 10518537 [TBL] [Abstract][Full Text] [Related]
20. Cell cycle and death control: long live Forkheads. Burgering BM; Kops GJ Trends Biochem Sci; 2002 Jul; 27(7):352-60. PubMed ID: 12114024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]